Clinical Trials List
2020-11-30 - 2027-12-31
Phase III
Recruiting4
ICD-10I25.10
Atherosclerotic heart disease of native coronary artery without angina pectoris
ICD-9429.2
Cardiovascular disease, unspecified
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 林柏志 無
- HUNG-JU LIN 無
- 陳盈憲 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Cheng-An Chiu 無
- 盧怡旭/朱俊源/許超/邱正安/吳韋璁/黃天祈 無
- Chun-Yuan Chu 無
- Po-Chao Hsu 無
- 吳韋璁 無
- 黃天祈 無
- Ye-Hsu Lu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
320 participants
